e-learning
resources
European Respiratory Review
2015
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Pulmonary arterial hypertension: the burden of disease and impact on quality of life
Delcroix Marion, Howard Luke
Source:
Eur Respir Rev 2015; 24: 621-629
Journal Issue:
December
Disease area:
Pulmonary vascular diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Delcroix Marion, Howard Luke. Pulmonary arterial hypertension: the burden of disease and impact on quality of life. Eur Respir Rev 2015; 24: 621-629
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The definition of pulmonary hypertension: history, practical implications and current controversies
Should we screen for hereditary pulmonary hypertension?
Patient with ankylosing spondylitis and pulmonary hypertension
Related content which might interest you:
Assessment of quality of life and social and economic impact of the disease in patients with pulmonary arterial hypertension in Germany – Data of the SANTANA-Study
Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension
Year: 2020
Relation of the novel pulmonary hypertension emPHasis10 quality of life score to markers of disease severity
Source: International Congress 2015 – Pulmonary hypertension: management
Year: 2015
The influence of psycho-social factors in the evolution of pulmonary hypertension patients
Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I
Year: 2013
Em
PH
asis-10 is associated with clinical outcome measures in pulmonary hypertension
Source: Annual Congress 2013 –Pulmonary circulation: clinical diagnosis, imaging, biomarkers and treatment
Year: 2013
Relationship of quality of life and life expectancy with tolerance to physical exercises and cardio respiratory parameters in patients with pulmonary arterial hypertension
Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases
Year: 2013
Measurement of quality of life in pulmonary hypertension and its significance
Source: Eur Respir J 2006 Oct 01;28(4):808-815
Year: 2006
Health-related quality of life and disease progression in pulmonary arterial hypertension patients: a 3-year study
Source: ERJ Open Res, 7 (3) 00617-2020; 10.1183/23120541.00617-2020
Year: 2021
Comparison of cardiac and pulmonary-specific quality-of-life measures in pulmonary arterial hypertension
Source: Eur Respir J 2011; 38: 608-616
Year: 2011
Impact of riociguat on health-related quality of life (HRQoL) in patients with pulmonary arterial hypertension (PAH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
Impact of insomnia on exercise capacity and quality of life in patients with pulmonary arterial hypertension
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Health-related quality of life in patients with pulmonary arterial hypertension
Source: Annual Congress 2011 - Clinical features of pulmonary hypertension
Year: 2011
Impact of riociguat on health-related quality of life (HRQoL) in patients with chronic thromboembolic pulmonary hypertension (CTEPH)
Source: Annual Congress 2013 –Pulmonary circulation: clinical science and treatment
Year: 2013
emPHasis-10: development of a health-related quality of life measure in pulmonary hypertension
Source: Eur Respir J 2014; 43: 1106-1113
Year: 2014
Quality of life and physical functioning in chronic thromboembolic pulmonary hypertension (CTEPH): the impact of treatment
Source: International Congress 2017 – PAH and CTEPH
Year: 2017
Sildenafil improves health-related quality of life in pulmonary arterial hypertension (PAH) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 563s
Year: 2005
EmPHasis-10 as a measure of health-related quality of life in pulmonary arterial hypertension: data from PHAR
Source: Eur Respir J, 57 (2) 2000414; 10.1183/13993003.00414-2020
Year: 2021
The burden of pulmonary hypertension
Source: Eur Respir J 2007; 30: 1-2
Year: 2007
The study of risk in pulmonary arterial hypertension
Source: Eur Respir Rev 2012 21:234-238
Year: 2012
Effects of tadalafil on health-related quality of life in patients with pulmonary arterial hypertension
Source: Annual Congress 2009 - Pulmonary arterial hypertension
Year: 2009
Exercise tests and anxiety independently reflect physical quality of life in patients with pulmonary arterial hypertension or chronic thromboembolic pulmonary hypertension
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept